Coronary disease & ACS

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial

LancetPublished Randomised controlled trial

An erratum to this article was published (Lancet, 11 May 2024 ↗)

Primary result · Target vessel failureResult — go to the resultHazard ratio 0.55 95% CI 0.41–0.74

Authors' conclusion

In patients with an acute coronary syndrome, intravascular ultrasound-guided implantation of contemporary drug-eluting stents resulted in a lower 1-year rate of the composite outcome of cardiac death, target vessel myocardial infarction, or clinically driven revascularisation compared with angiography guidance alone.

Study context

Population
Patients aged ≥18 years presenting with ACS undergoing PCI with contemporary drug-eluting stents3,504 (>99.9%) completed 1-year follow-up
Participants
3,505 patients
Comparison
IVUS-guided PCI vs angiography-guided PCI
  • Intravascular ultrasoundn = 1,753
  • Angiographyn = 1,752reference
Primary endpoint
Target vessel failure:
  • Cardiac death
  • Target vessel MI
  • Clinically driven target vessel revascularisation
Follow-up
1 year after randomisation
Methodological detailstwo-stage, multicentre, 58 centres in China, Italy, Pakistan and the UK, patients, follow-up providers and assessors masked; catheterisation laboratory staff not masked
  • Two-stage
  • Multicentre
  • 58 centres in China, Italy, Pakistan and the UK
  • Patients, follow-up providers and assessors masked; catheterisation laboratory staff not masked

Primary result

Target vessel failure · 1 year

Hazard ratio

0.55

95% CI 0.41–0.74

P = 0.0001

Events by treatment group

IVUS vs Angiography
HR 0.55 (95% CI 0.41–0.74); P = 0.0001

As reported in the abstract

Further findings

All-cause death, stent thrombosis

No significant differences between groups

Original publication

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet. Published 8 April 2024. doi:10.1016/s0140-6736(24)00282-4

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.